CVS Health Reports Second Quarter Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/12/2026
- US stock futures gain ahead of July inflation data
- Oil prices rise after ship attacks, US-Iran talks deadlock
- CoreWeave soars after fifth straight quarter of record revenue, raised guide
- Four key things investors will watch in Nvidia's earnings next week
- Silver could surge to $90 as investment demand takes over, Citi says
- Lumentum Holdings (LITE) Tops Q4 EPS by 28c, Beats on Revenue; Offers Q1 Guidance
- Aurora Cannabis rejects Curaleaf's unsolicited $4-per-share takeover bid
- AbCellera Biologics (ABCL) PT Raised to $30 at Truist on 'best-in-class potential'
- Wall Street ends down as US-Iran peace optimism fades
- Comscore plans restructuring with $20M-$25M in cost cuts
- After-Hours Movers: CRWV, NBIS, SMCI, LITE, CAVA, HRB
- After-Hours Movers: P, RIOT, BW, RKLB, HIMS, UPWK
- After-Hours Movers: TEAM, NET, TWLO, DOCS, FROG, DV, TTD, ABNB, DKNG, SG, RKT
- After-Hours Stock Movers: WDC, SNDK, FIG, APP, HUBS, SOUN, DASH, XYZ, Z, FLNC
- After-Hours Movers: SPCX, AMD, ANET, PINS, APPS, UPST, ZETA, BKNG, LCID, CPNG, MTCH
CVS Health (CVS) PT Raised to $90 at RBC Capital
August 9, 2018 8:21 AM EDTRBC Capital raised its price target on CVS Health (NYSE: CVS) to $90.00 (from $84.00) while maintaining an Outperform rating.
Analyst George Hill views the updates on the Aetna transaction, PBM rebate retention, and the potential impact of regulatory changes positively and largely in-line with our positive view.
... MoreCVS Health (CVS) Tops Q2 EPS by 8c
August 8, 2018 6:57 AM EDTCVS Health (NYSE: CVS) reported Q2 EPS of $1.69, $0.08 better than the analyst estimate of $1.61. Revenue for the quarter came in at $46.7 billion versus the consensus estimate of $46.34 billion.
Same store sales increased 5.9% and pharmacy same store sales increased 8.3% in the three months ended... More
